FDA Breakthrough Device Designation granted to Sooma for Its Innovative At-Home Depression Treatment Device We are proud to announce the U.S. Food and Drug Administration (FDA) has granted Sooma… Read more
New European Regulation reclassifies brain stimulation equipment without an intended medical purpose as class III Disclaimer: This change does not impact Sooma, Sooma’s customers, or patients using Sooma devices. The… Read more
Sooma’s latest study provides the largest dataset to date on the effects of tDCS for treating MDD in real-world clinical practice Since the publication of our 2019 white paper, we have been working on updating our clinical data regarding the… Read more
Sooma reaches more than 10,000 patients treated with its tDCS devices Mental health crisis is an urgent issue in all countries. More and more patients are becoming chronically ill… Read more
Sooma starts a collaboration with the Non-Invasive Brain Stimulation Lab at University Medical Center (Göttingen) Sooma and the Non-Invasive Brain Stimulation (NBS) Lab have kick-started a collaboration to conduct a clinical trial with 80… Read more
tDCS therapies are now reimbursed in Estonia Psychiatric and neuropathic patients in Estonia can now access tDCS treatments more efficiently, as the Estonian public healthcare system is… Read more
Sooma welcomes a new Scientific Board Member We are thrilled to announce the addition of a new member to our Scientific Advisory Board (SAB). This brings the… Read more
Sooma joins the Finnish Startup Community A new community for startups has been born today in Finland. The Finnish Startup Community (Suomen startup-yhteisö) is a community… Read more
New U.S. patent granted to Sooma’s electrode structure Sooma Medical has been granted a new U.S. patent for its stimulation electrode. The electrode technology is an essential… Read more
New European regulation identifies brain stimulation devices approved for medical use Understanding medical device regulations can be a struggle. Rapid technological development is often a headache in terms of regulations, and… Read more
